Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4163391000168110 | Olmesartan HCTZ 20/12.5 (AKM) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4163401000168112 | Olmesartan HCTZ 20/12.5 (AKM) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olmesartan HCTZ 20/12.5 (AKM) tablet, 10, blister pack | has TPUU | True | Olmesartan HCTZ 20/12.5 (AKM) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (AKM) tablet, 10 | has TPUU | True | Olmesartan HCTZ 20/12.5 (AKM) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (AKM) tablet, 30 | has TPUU | True | Olmesartan HCTZ 20/12.5 (AKM) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (AKM) tablet, 30, blister pack | has TPUU | True | Olmesartan HCTZ 20/12.5 (AKM) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (AKM) tablet, 30, bottle | has TPUU | True | Olmesartan HCTZ 20/12.5 (AKM) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set